T-477, a novel Ca 2+ - and Na + channel blocker, prevents veratridine-induced neuronal injury

By Okuyama K.   Kiuchi S.   Okamoto M.   Narita H.   Kudo Y.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Parallel dose-response studies of the voltage-dependent Na + channel antagonist BW619C89, and the voltage-dependent Ca 2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia

By Kawaguchi K.   Henshall D.C.   Simon R.P.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 99-105

Elsevier

Access to resources Recommend Favorite

Comparison of the stimulus properties of ethanol and the Ca 2+ channel antagonist nimodipine in rats

By De Beun R.   Lohmann A.   Schneider R.   De Vry J.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 5-13

Elsevier

Access to resources Recommend Favorite

A novel benzothiazine Ca 2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca 2+ currents

By Koidl B.   Miyawaki N.   Tritthart H.A.  

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

The therapeutic potential of Na⁺ and Ca²⁺ channel blockers in pain management

By Sabido-David Cibele   Faravelli Laura   Salvati Patricia  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1249-1261

Informa Healthcare

Access to resources Recommend Favorite